Percutaneous recanalization for Budd-Chiari syndrome: An 11-year retrospective study on patency and survival in 177 Chinese patients from a single center

Radiology

Volumn 266, Issue 2, 2013, Pages 657-667

  Han, Guohong ^a   Qi, Xingshun ^a   Zhang, Wei ^a   He, Chuangye ^a   Yin, Zhanxin ^a   Wang, Jianhong ^a   Xia, Jielai ^b   Xu, Ke ^c   Guo, Wengang ^a   Niu, Jing ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; NITROGEN; UREA;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; BUDD CHIARI SYNDROME; CANCER PATIENT; CANCER SURVIVAL; CHILD; CHINESE; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS RECANALIZATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECANALIZATION; RETROSPECTIVE STUDY; SCHOOL CHILD; STENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSHEPATIC APPROACH; TRANSJUGULAR APPROACH; UREA NITROGEN BLOOD LEVEL; VASCULAR PATENCY;

ADULT; ANALYSIS OF VARIANCE; ANGIOPLASTY; BUDD-CHIARI SYNDROME; CHI-SQUARE DISTRIBUTION; CHINA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84873376353     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120856     Document Type: Article

References (29)

1. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009;50(1):195-203.
2. De Leve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009;49(5):1729- 1764.
3. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44(5):1308-1316.
4. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151(3):167-175.
5. Valla DC. Hepatic venous outfow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19(Suppl 7):S204-S211.
6. Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther 2011;33(10):1087-1103.
7. Darwish Murad S, Valla DC, De Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39(2):500-508.
8. Qi X, Zhang C, Han G, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 2012;27(6):1036-1043.
9. Okuda H, Yamagata H, Obata H, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22(1):1-9.
10. Wu T, Wang L, Xiao Q, et al. Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 2002;83(2):175-178.
11. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 2003;9(11):2587-2591.
12. Xu K, Feng B, Zhong H, et al. Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J (Engl) 2003;116(4):609-615.
13. Xue H, Li YC, Shakya P, Palikhe M, Jha RK. The role of intravascular intervention in the management of Budd-Chiari syndrome. Dig Dis Sci 2010;55(9):2659-2663.
14. Qiao T, Liu CJ, Liu C, Chen K, Zhang XB, Zu MH. Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly 2005;135(21-22):318-326.
15. Li T, Zhai S, Pang Z, et al. Feasibility and midterm outcomes of percutaneous transhepatic balloon angioplasty for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. J Vasc Surg 2009;50(5):1079-1084.
16. Yang XL, Cheng TO, Chen CR. Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava:8-year follow-up study. J Am Coll Cardiol 1996;28(7):1720-1724.
17. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006;55(6):878-884.
18. Griffth JF, Mahmoud AE, Cooper S, Elias E, West RJ, Olliff SP. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol 1996;51(11):775-784.
19. Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44(4):568-574.
20. Rautou PE, Douarin L, Denninger MH, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol 2011;54(1):56-63.
21. Pelage JP, Denys A, Valla D, et al. Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol 2003;13(2):286-293.
22. Xu K, He FX, Zhang HG, et al. Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement. Cardiovasc Intervent Radiol 1996;19(1):32-36.
23. Sato M, Yamada R, Tsuji K, et al. Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol 1990;13(3):189-192.
24. Martin LG, Henderson JM, Millikan WJ Jr, Casarella WJ, Kaufman SL. Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. AJR Am J Roentgenol 1990;154(5):1007-1010.
25. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135(3):808-815.
26. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 2006;44(3):520-528.
27. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39(4):496-501.
28. Rautou PE, Moucari R, Escolano S, et al. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 2009;104(5):1140-1146.
29. Bachet JB, Condat B, Hagège H, et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46(1):60-68.